Breast cancer tumor growth estimated through mammography screening data

Breast Cancer Research

Volumn 10, Issue 3, 2008, Pages

  Weedon Fekjær, Harald ^a,b   Lindqvist, Bo H ^c   Vatten, Lars J ^c   Aalen, Odd O ^b   Tretli, Steinar ^a,c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; MAMMOGRAPHY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NORWAY; PATHOLOGY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

AGED; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; NORWAY; SENSITIVITY AND SPECIFICITY;

EID: 55449109611     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2092     Document Type: Article

References (39)

1. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353:1784-1792. 10.1056/NEJMoa050518, 16251534.
2. Spratt JS, Meyer JS, Spratt JA. Rates of growth of human solid neoplasms: part I. J Surg Oncol 1995, 60:137-146. 10.1002/jso.2930600216, 7564383.
3. Spratt JS, Meyer JS, Spratt JA. Rates of growth of human neoplasms: part II. J Surg Oncol 1996, 61:68-83. 10.1002/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E, 8544465.
4. Peer PG, van Dijck JA, Hendriks JH, Holland R, Verbeek AL. Age-dependent growth rate of primary breast cancer. Cancer 1993, 71:3547-3551. 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2 -C, 8490903.
5. Prevost TC, Launoy G, Duffy SW, Chen HH. Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. Am J Epidemiol 1998, 148:609-619.
6. Karlin S, Taylor H. An Introduction to Stochastic Modeling 1998, Academic Press, New York.
7. Chen HH, Prey MU, Babcock DS, Day NE. Breast carcinoma cell kinetics, morphology, stage, and the preclinical screen-detectable phase. Lab Invest 1997, 2:9-23.
8. van Oortmarssen GJ, Habbema JD, Maas PJ, de Koning HJ, Collette HJ, Verbeek AL, Geerts AT, Lubbe KT. A model for breast cancer screening. Cancer 1990, 66:1601-1612. 10.1002/1097-0142(19901001)66:7<1601::AID-CNCR2820660727>3.0.CO;2- O, 2119877.
9. Spratt JA, von Fournier D, Spratt JS, Weber EE. Decelerating growth and human breast cancer. Cancer 1993, 71:2013-2019. 10.1002/1097-0142(19930315)71:6<2013::AID-CNCR2820710615>3.0.CO;2- V, 8443753.
10. Wang H, Kåresen R, Hervik A, Thoresen S. Mammography screening in Norway; results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening. Cancer Causes Control. 2001, 1:39-45. 11227924, 10.1023/A:1008999403069.
11. Cancer in Norway 2006. , http://www.kreftregisteret.no
12. Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984, 40:1-14. 10.2307/2530739, 6733223.
13. Duffy SW, Chen HH, Prevost TC, Tabár L. Markov chain models of breast tumour progression and its arrest by screening. Quantitative Methods for the Evaluation of Cancer Screening 2001, 42-60. Arnold, London.
14. Duffy SW, Chen HH, Tabar L, Day NE. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat Med 1995, 14:1531-1543. 10.1002/sim.4780141404, 7481190.
15. Habbema JD, van Oortmarssen GJ, Lubbe JT, Maas PJ. The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed 1985, 20:79-93. 10.1016/0169-2607(85)90048-3, 3849380.
16. Hartveit F, Maehle BO, Pettersen KC. Size of breast carcinomas at operation related to tumour growth rate. Breast Cancer Res Treat 1987, 10:47-50. 10.1007/BF01806134, 3689981.
17. Hart D, Shochat E, Agur Z. The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer 1998, 78:382-387.
18. Norton L. A Gompertzian model of human breast cancer growth. Cancer Res 1988, 48:7067-7071.
19. Spratt JA, von Fournier D, Spratt JS, Weber EE. Mammographic assessment of human breast cancer growth and duration. Cancer 1993, 71:2020-2026. 10.1002/1097-0142(19930315)71:6<2020::AID-CNCR2820710616>3.0.CO;2- #, 8443754.
20. Meyer JS, Prey MU, Babcock DS, Mcdivitt RW. Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study. Lab Invest 1986, 54:41-51.
21. Moller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, Haldorsen T. The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 2005, 14:117-128. 10.1097/00008469-200504000-00007, 15785315.
22. Bakken K, Alsaker E, Eggen AE, Lund E. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. Int J Cancer 2004, 112:130-134. 10.1002/ijc.20389, 15305384.
23. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427. 10.1016/S0140-6736(03)14596-5, 12927427.
24. R. , http://www.r-project.org
25. Chernick MR. Bootstrap Methods: A Practitioner's Guide 1999, Wiley-Interscience, USA.
26. Weedon-Fekjaer H, Vatten LJ, Aalen OO, Lindqvist B, Tretli S. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening; new results. J Med Screen 2005, 12:172-178. 10.1258/096914105775220732, 16417693.
27. Brown BW, Atkinson EN, Bartoszynski R, Thompson JR, Montague ED. Estimation of human tumor growth rate from distribution of tumor size at detection. J Natl Cancer Inst 1984, 72:31-38.
28. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992, 84:781-785. 10.1093/jnci/84.10.781, 1573665.
29. Porter PL, El Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 1999, 91:2020-2028. 10.1093/jnci/91.23.2020, 10580027.
30. Kavanagh AM, Mitchell H, Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet 2000, 355:270-274. 10.1016/S0140-6736(99)07319-5, 10675074.
31. Litherland JC, Stallard S, Hole D, Cordiner C. The effect of hormone replacement therapy on the sensitivity of screening mammograms. Clin Radiol 1999, 54:285-288. 10.1016/S0009-9260(99)90555-X, 10362232.
32. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995, 75:2507-2517. 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2 -H, 7736395.
33. Paci E, Duffy SW. Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). Int J Epidemiol 1991, 20:852-858. 10.1093/ije/20.4.852, 1800422.
34. Hofvind S, Geller B, Vacek PM, Thoresen S, Skaane P. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 2007, 22:447-455. 10.1007/s10654-007-9137-y, 17594526.
35. Plevritis SK. A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening. Math Biosci 2001, 171:155-178. 10.1016/S0025-5564(01)00054-2, 11395049.
36. Maas PJ, de Koning HJ, van Ineveld BM, van Oortmarssen GJ, Habbema JD, Lubbe KT, Geerts AT, Collette HJ, Verbeek AL, Hendriks JH, Rombach JJ. The cost-effectiveness of breast cancer screening. Int J Cancer 1989, 43:1055-1060. 10.1002/ijc.2910430617, 2499553.
37. Cancer Intervention and Surveillance Modeling Network. , http://cisnet.cancer.gov/
38. World Health Organization IARC Handbooks of Cancer Prevention: Handbook 7: Breast Cancer Screening 2001, IARC Press, Lyon, France, World Health Organization.
39. Ross MB, Buzdar AU, Hortobagyi GN, Lukeman JM. Spontaneous regression of breast carcinoma: follow-up report and literature review. J Surg Oncol 1982, 19:22-24. 10.1002/jso.2930190107, 7057640.